US Executive Officer Management Changes SEC — March 17, 2026

17-03-2026

On March 15, 2026, Sean Smith resigned as Chief Accounting Officer of QXO, Inc., effective immediately, to pursue employment closer to his family, and agreed to serve in an advisory role until June 30, 2026, with continued compensation including prorated salary, bonus, and equity vesting. The departure is not due to any disagreements on accounting principles, financial statements, or internal controls. On March 16, 2026, Robert Loughran was appointed as Interim Chief Accounting Officer, effective immediately, while the company searches for a permanent successor.

• ·No family relationships between Mr. Loughran and any directors or executive officers.
• ·No arrangements or understandings pursuant to which Mr. Loughran was selected as an officer.
• ·No material transactions involving Mr. Loughran subject to Item 404(a) of Regulation S-K.
• ·Mr. Loughran's prior roles: Partner at Elm Street Advisors (since 2023), CFO at Greenidge Generation Holdings (Jan 2022-Oct 2023), CAO at Greenidge (Jun 2021-Jan 2022), VP Corporate Controller at Tronox Holdings PLC (Apr 2018-Jun 2020), various senior roles at Avon including Group VP CAO (Mar 2016-Mar 2019) and VP Corporate Controller (May 2012-Mar 2016).
• ·Mr. Loughran is a Certified Public Accountant with a BS from University of Connecticut.

17-03-2026

Personalis, Inc. appointed Richard Chen as President on March 13, 2026, in addition to his existing roles as Executive Vice President, R&D, and Chief Medical Officer, based on the recommendation of CEO Christopher Hall, who previously served as President. In connection with the appointment, Dr. Chen's annual base salary will increase to $570,000 effective April 1, 2026, with his performance bonus target raised to 70% of base salary. He will also receive stock options for 37,500 shares and RSUs covering 6,250 shares, granted on March 15, 2026, under the 2019 Equity Incentive Plan.

• ·Richard Chen, age 55, has served as EVP R&D since March 2023, CMO since July 2021, SVP R&D from July 2021 to March 2023, and Chief Scientific Officer from November 2011 to July 2021.
• ·Stock options vest in equal monthly installments over 36 months; RSUs vest 1/6 on six-month anniversary of March 15, 2026, and bi-annually thereafter, subject to continuous service.
• ·Dr. Chen co-founded Ingenuity Systems in August 1997 and has been clinical faculty at Stanford since September 2011; holds B.S., M.S., and M.D. from Stanford.

17-03-2026

First Industrial Realty Trust, Inc. (NYSE: FR) announced the appointment of Frank E. Schmitz to its Board of Directors effective June 1, 2026, expanding the board to seven members, six of whom are independent. The Board also authorized a new $250 million share repurchase program with no expiration date, to be executed opportunistically, and plans to host market tours for investors and analysts in 2026. As of December 31, 2025, the company owns and has under development approximately 71.6 million square feet of industrial space in 15 target MSAs.

• ·Preliminary proxy statement filed February 27, 2026, for 2026 Annual Meeting of Stockholders.
• ·Frank E. Schmitz's background includes co-founding Park Hill Real Estate Group in 2005 and heading Principal’s $12B real estate equity group.

17-03-2026

On March 12, 2026, Erin Nealy Cox resigned from the Board of Directors of Sally Beauty Holdings, Inc., effective immediately, as she transitions to a new role at Walmart, Inc. There was no disagreement between Ms. Nealy Cox and the Company leading to her resignation, and her term was scheduled to expire at the 2027 Annual Meeting of Stockholders. The Company thanked her for her service and leadership.

17-03-2026

Bicycle Therapeutics reported Q4 and FY 2025 financial results showing collaboration revenue surging to $48.0M (Q4, +$44.3M YoY) and $72.6M (FY, +$37.3M YoY), with Q4 net loss improving to $20.2M from $51.9M, but FY net loss widening to $219.0M from $169.0M amid higher R&D expenses ($240.3M, +$67.3M YoY). Cash stood at $628.1M (down from $879.5M), extended to 2030 via 30% workforce reduction and ~50% op ex cut, while deprioritizing zelenectide (Duravelo-2 converted to Phase 2 despite 58-65% ORR) to focus on BT5528 and BRCs. Leadership changes include new COO Jennifer Perry and CCDO Alistair Milnes, with promotions for CFO Travis Thompson and CMO Michael Method.

• ·15-year contract with UK NDA for up to 400 tonnes of reprocessed uranium (RepU).
• ·Q4 R&D expenses $51.8M (+4% YoY), G&A $20.9M (-3.2% YoY).
• ·Plans to discontinue internal development of BT7480 post combination data and seek partner.
• ·Phase 2 trial for nuzefatide in PDAC enrolling since March 2026.

17-03-2026

Redwire Corporation (NYSE: RDW) elected The Honorable Frank Calvelli to its Board of Directors, effective March 12, 2026, as announced in a press release dated March 17, 2026. Calvelli, with over 36 years of experience including as Assistant Secretary of the Air Force for Space Acquisition and Integration and Principal Deputy Director of the National Reconnaissance Office, brings expertise in U.S. Space Force programs and national security space acquisitions. Redwire Chairman and CEO Peter Cannito highlighted Calvelli's value for the company's growth in delivering capabilities for U.S. warfighters.

• ·Calvelli earned a bachelor’s degree in computer and information sciences from the State University of New York at Potsdam and an MBA from Loyola College in Baltimore, Maryland.
• ·Media Contact: Tere.Riley@rdw.com; Investors: Investorrelations@rdw.com

17-03-2026

Frontdoor, Inc. (NASDAQ: FTDR) announced the unanimous election of Dennis Howard to its Board of Directors and appointment to the Audit Committee, effective March 17, 2026. Howard, currently Managing Director, Chief Technology, Operations, and Data Officer at Charles Schwab, brings over 30 years of experience in IT, cybersecurity, operations, and innovation from roles at Charles Schwab and Visa Inc. The company, with over 55 years of experience, serves more than 2.1 million members, handling 3.8 million service requests annually through a network of 17,000 contractors.

• ·Howard joined Charles Schwab in September 2014 as Senior Vice President of core technology solutions.
• ·Served as Executive Vice President and Chief Information Officer at Charles Schwab from 2016-2025.
• ·12-year tenure at Visa Inc. in various IT roles.
• ·Bachelor's degree from University of Texas at San Antonio; Master's from Baylor University.
• ·Howard will stand for re-election at Frontdoor's 2026 annual meeting of stockholders.

17-03-2026

On March 17, 2026, Churchill Capital Corp XI appointed Paul Lapping and Stephen Murphy as directors, effective immediately, with both joining the compensation and audit committees; Lapping replaced William Sherman as Audit Committee chairperson, though Sherman remains a member. The Board expanded its first class of directors, whose terms expire at the first annual general meeting. The Company entered into director agreements with Lapping, Murphy, and Sherman providing $75,000 annual cash compensation per director, starting April 1, 2026.

• ·Paul Lapping, age 63, brings SPAC board experience from Churchill IX and X, prior CFO roles in SPACs, and private equity background.
• ·Stephen Murphy, age 62, has SPAC experience from Churchill IX, X, VI, and VII, plus investment banking at Salomon Brothers and Citigroup.
• ·New directors signed joinder to December 16, 2025 letter agreement waiving certain redemption rights and committing to vote in favor of initial business combination.
• ·No family relationships or related-party transactions involving new directors.

17-03-2026

Parsons Corporation (NYSE: PSN) announced the promotion of Soo Lagasse to Chief Human Resources Officer (CHRO) effective April 1, 2026, succeeding Susan Balaguer, who will retire by the end of May 2026 after nearly five years transforming the HR function. Balaguer achieved hiring records, attrition goals, and aligned benefits and leadership development with the 'People First' culture. Lagasse, who joined in 2021 with three decades of experience, led record hiring quarters, expanded university/intern programs, and enhanced global mobility.

• ·Lagasse joined Parsons in 2021.
• ·Balaguer served nearly five years and specifically four and a half years in quoted remarks.
• ·Media contact: Bernadette Miller +1 980.253.9781 Bernadette.Miller@parsons.com
• ·IR contact: Dave Spille +1 703.775.6191 Dave.Spille@parsons.us
• ·Parsons operates in national security and global infrastructure markets including cyber/electronic warfare, space/missile defense, transportation, water/environment, urban development, and critical infrastructure protection.

17-03-2026

Hinge Health, Inc. appointed Tyler Sloat as a Class I Director effective March 16, 2026, with his term expiring at the 2026 annual stockholder meeting; he was also appointed Chair of the Compensation Committee and a member of the Audit Committee. Mr. Sloat, current COO of Freshworks Inc. (since August 2024) and former CFO of Zuora Inc. (2010-2020), will receive standard non-employee director compensation including an initial $400,000 RSU award vesting over three years and pro-rated annual cash fees of $65,000 (elected as RSUs). No arrangements, family relationships, or related-party transactions were disclosed.

• ·Mr. Sloat holds a B.A. in Economics from Boston College and an M.B.A. from Stanford University Graduate School of Business; registered (inactive) CPA in California.
• ·RSUs vest annually over three years or in full upon Change in Control, subject to continued service.
• ·Standard indemnification agreement to be entered with Mr. Sloat.

17-03-2026

Peloton Interactive, Inc. (PTON) appointed Sarah Robb O’Hagan as Chief Content and Member Development Officer, effective April 1, 2026, reporting to President and CEO Peter Stern, to accelerate content innovation, member engagement, and the shift to a connected wellness strategy targeting sustainable profitable growth. She succeeds Jen Cotter, who is departing after seven years but will serve as an advisor through mid-August 2026. Robb O’Hagan brings extensive experience from CEO of EXOS, President of Gatorade ($5B business turnaround), and roles at Equinox, Nike, Flywheel Sports, and Strava.

• ·Peloton founded in 2012 and headquartered in New York City
• ·Peloton has millions of Members across the US, UK, Canada, Germany, Australia, and Austria
• ·Robb O’Hagan named one of Fast Company’s 'Most Creative People in Business' and Forbes’ 'Most Powerful Women in Sports'

17-03-2026

Mangoceuticals, Inc. (NASDAQ: MGRX) announced it filed a civil lawsuit in Texas state court against former vendor Clarity Ventures, Inc., seeking damages exceeding $73 million for allegedly failing to deliver a functional HIPAA-compliant ERP and eCommerce platform. Clarity has asserted counterclaims for unpaid invoices, which the company disputes as unwarranted since all required payments were made. The company has since developed its own proprietary telehealth and eCommerce platform internally, which management states has improved customer acquisition, order fulfillment, and operating performance, though all claims remain unproven in court.

• ·Lawsuit filed in Texas state court.
• ·Company's current platform developed internally without reliance on Clarity’s technology.
• ·References to SEC filings: Annual Report on Form 10-K for year ended December 31, 2024; Quarterly Report on Form 10-Q for quarter ended September 30, 2025.

17-03-2026

Taylor Morrison Home Corp announced that Board member David Merritt notified the company of his decision to retire from the Board effective at the 2026 Annual Meeting of Stockholders, with no disagreements on operations, policies, or practices. In connection, the Board approved reducing its size from nine to eight members.

• ·Event reported on March 11, 2026; filing dated March 17, 2026.
• ·Common Stock trades as TMHC on New York Stock Exchange.

17-03-2026

Navitas Semiconductor Corporation disclosed the departure of Todd Glickman, former Senior Vice President, Chief Financial Officer, and Treasurer, who will serve as a consultant until the Transition Date of March 30, 2026, to ensure a smooth handover. Tonya Stevens will become the incoming Chief Financial Officer and Treasurer effective March 30, 2026. On March 13, 2026, the company accelerated the vesting of 211,528 previously unvested restricted stock units for Glickman, originally scheduled for September 20, 2026.

• ·Previously disclosed in 8-K filings on February 24, 2026 and March 11, 2026
• ·Departure described as mutual decision to pursue new opportunities
• ·Report signed by Chris Allexandre on March 17, 2026

17-03-2026

Coursera, Inc. appointed Michael Foley, age 52, as permanent Senior Vice President, Chief Financial Officer, and Treasurer effective March 16, 2026, following his interim role. The new offer letter sets his annual base salary at $475,000, target annual bonus at 70% of base salary with a 2026 minimum of $200,000, and grants 350,000 RSUs vesting over four years starting February 15, 2027, plus 350,000 PSUs tied to 2026 financial goals. No family relationships, related transactions, or other arrangements were disclosed.

• ·RSUs vest 25% on February 15, 2027, remainder in equal quarterly installments.
• ·PSUs subject to 2026 financial performance certification by HRC Committee, with 25% vesting on February 15, 2027 if eligible.
• ·Mr. Foley participates in Amended and Restated Executive Severance Plan as Class A Executive effective March 16, 2026.
• ·Prior interim offer letter dated November 13, 2025 superseded.

17-03-2026

On March 11, 2026, Suzanne Seandel notified 8x8, Inc. of her resignation as Chief Accounting Officer and principal accounting officer, effective at a mutually agreeable date expected in mid-April 2026, not due to any disagreement with company operations, policies, or practices. The company plans a consulting arrangement with Ms. Seandel through May 31, 2026, and has commenced a search for her successor. Effective the separation date, Kevin Kraus, the current Chief Financial Officer, will be appointed principal accounting officer with no new compensatory agreements.

• ·Kevin Kraus, age 56, was appointed permanent CFO on June 5, 2023, after serving as Interim CFO from November 2022 to June 2023 and SVP of Finance since October 2019.
• ·Prior to 8x8, Kevin Kraus was VP of Finance at Imperva (2018-2019) and Senior Director of Finance at Gigamon (2015-2017).
• ·Mr. Kraus holds a bachelor’s degree in accounting from Rutgers University and an MBA from Pennsylvania State University.
• ·No family relationships or material conflicts of interest for Mr. Kraus.

17-03-2026

On March 13, 2026, Jaisim Shah retired as CEO, President, and Director of Semnur Pharmaceuticals, Inc., resulting in the board size decreasing from six to five members, with no disagreements on company matters. Henry Ji, Ph.D., previously Executive Chairperson, was immediately appointed as new CEO and President, while Stephen Ma, former CFO, was named COO effective March 17, 2026, with no changes to their compensation. Shah received a separation agreement providing six months of base salary continuation at a $1.25M annual rate.

• ·Shah granted 90-day extension to exercise vested stock options.
• ·No family relationships or disclosable related party transactions under Item 404(a) for Ji or Ma beyond Scilex ties.
• ·Company is an emerging growth company trading on OTCQB.

17-03-2026

Kevin A. Lobo notified Parker-Hannifin Corporation on March 13, 2026, that he will not stand for reelection to the Board of Directors at the 2026 Annual Meeting of Shareholders due to his election to the Board of GE HealthCare Technologies Inc. Mr. Lobo, who has served as a director since 2013, stated that his decision was not due to any disagreement with the company's operations, policies, or practices. He is expected to continue serving until the expiration of his current term.

• ·Filing signed by Joseph R. Leonti on March 17, 2026

17-03-2026

On March 16, 2026, David W. Johnson resigned from the Board of Directors of Hilton Grand Vacations Inc. effective immediately, with no disagreement on operations, policies, or practices. In connection with the resignation, the Board size was reduced from 10 to 9 directors.

• ·Resignation reported in Form 8-K filed on March 17, 2026
• ·Company headquartered at 6355 MetroWest Boulevard, Suite 180, Orlando, Florida 32835

17-03-2026

On March 15, 2026, Susan B. McGee notified the Board of Goldman Sachs BDC, Inc. that she intends to resign from the Board and all committees thereof, effective March 31, 2026. The Company and Board expressed gratitude for her service and anticipate her contributions until the end of her tenure. The 8-K was filed on March 17, 2026, and signed by Co-Chief Executive Officers Vivek Bantwal and David Miller.

• ·Principal executive offices: 200 West Street, New York, New York 10282
• ·Registrant’s telephone number: (312) 655-4419
• ·Common Stock trading symbol: GSBD on The New York Stock Exchange

17-03-2026

On March 12, 2026, ImageneBio, Inc. (NASDAQ: IMA) announced a mutual separation from Erin Butler, Senior Vice President, Finance & Administration and Principal Accounting Officer, effective March 20, 2026, with severance benefits per her October 21, 2024 agreement. Effective the same date, the board appointed Bob Lally, current Senior Vice President, Finance & Operations, as the new Principal Accounting Officer. No new compensatory arrangements, family relationships, or disclosable transactions were noted for Mr. Lally.

• ·Bob Lally served as SVP Finance & Operations at Ikena Oncology from December 2022 to July 2025; VP Finance (Feb 2019-Mar 2021) and COO (Mar 2021-Jun 2022) at Prevail Therapeutics; Executive Director Finance and Controller at Arsanis from May 2016 to March 2019.
• ·Holds B.S. in finance from University of Massachusetts, Lowell.
• ·Separation Agreement to reference Severance Rights Agreement filed as Exhibit 10.16 to 8-K on July 29, 2025.

17-03-2026

Primoris Services Corporation announced on March 12, 2026, that Director John P. Schauerman will not stand for re-election and will retire from the Board at the 2026 Annual Meeting of Stockholders, expected on April 30, 2026. The retirement is not due to any disagreement with the Company, where he has served since 2016 after prior roles including CFO from February 2008 to February 2009. The Company will not seek a replacement, reducing the Board size to eight members effective at the Annual Meeting.

• ·Filing signed on March 17, 2026
• ·Common Stock trades as PRIM on New York Stock Exchange

17-03-2026

Jefferson Capital, Inc.'s Board approved and ratified 2025 annual cash bonuses on March 11, 2025: $382,884 (100% of target) for CEO David Burton, totaling $3,795,973; $247,202 (86% of target) for Mark Zellmann, totaling $1,062,184; and $208,864 in performance-based commissions for Chief Commercial Officer Penelope Person (including $97,872 for Q4), totaling $633,060. This updates the 2025 Summary Compensation Table originally filed in the January 5, 2026 prospectus, where these incentive amounts were not yet determined.

• ·Prospectus filed January 5, 2026 (Registration Statement No. 333-292576) originally omitted 2025 bonuses and Q4 commissions.
• ·Company is an emerging growth company.
• ·Common stock (JCAP) registered on Nasdaq Global Select Market, $0.0001 par value.

17-03-2026

On March 12, 2026, Anthony Bacos, Chief Product and Technology Officer of Stitch Fix, Inc., notified the company of his intention to retire, effective August 1, 2026. The 8-K filing was submitted on March 17, 2026, under Item 5.02 for officer departure. No successor has been named in the filing.

• ·Stitch Fix, Inc. is incorporated in Delaware with I.R.S. Employer Identification No. 27-5026540 and principal offices at 1 Montgomery Street, Suite 1500, San Francisco, California 94104.
• ·Class A common stock trades under symbol SFIX on Nasdaq Global Select Market.

17-03-2026

DLH Holdings Corp. held its Annual Meeting on March 12, 2026, where shareholders elected seven directors (votes for: 7.7M-8.2M; withheld: 0.5M-1.1M) and approved an amendment to the 2025 Equity Incentive Plan increasing available shares by 550,000 (7.5M For vs. 1.3M Against). An advisory vote on named executive officer compensation passed (7.2M For vs. 1.5M Against), and the ratification of Withum, Smith + Brown, P.C. as auditor was approved overwhelmingly (12.4M For vs. 0.7M Against), with 13.2M shares represented out of 14.5M outstanding.

• ·Proposal 1 director votes - Dr. Frances M. Murphy: 7,718,784 For, 1,057,322 Withheld
• ·Proposal 2: 7,237,748 For, 1,535,776 Against, 2,582 Abstain
• ·Proposal 3: 7,475,351 For, 1,298,173 Against, 2,582 Abstain
• ·Proposal 4: 12,421,831 For, 747,718 Against, 2,992 Abstain
• ·Proxy statement filed January 28, 2026

17-03-2026

Cross Country Healthcare, Inc. (CCRN) reported that Phil Noe ceased serving as Chief Information Officer effective March 10, 2026, with no replacement announced. The company entered into a Separation Agreement providing Mr. Noe $205,975 in severance payments over six months and a Consulting Agreement for technology-related services from March 11 to May 31, 2026, at $198.04 per hour. This executive departure includes standard release provisions but no other financial or operational impacts disclosed.

• ·Separation Agreement and Consulting Agreement both dated March 16, 2026, filed as Exhibits 10.1 and 10.2
• ·Severance payments to be made in bi-weekly installments following seven-day revocation period
• ·Consulting Agreement terminable by mutual written agreement prior to May 31, 2026

17-03-2026

Four directors—Evan Hazell, Sondra Scott, David Smith, and Brad Virbitsky—resigned from Gran Tierra Energy Inc.'s Board effective March 11-12, 2026, citing disagreements with the Audit Committee majority over handling an independent investigation into an anonymous complaint unrelated to fraud or financial misstatements. The Board reduced its size from nine to five members amid the departures. The Audit Committee intends to continue the probe with management assistance and external advisors.

• ·Resigning directors served on key committees including Audit, Reserves, Health, Safety & Environment, Nominating and Corporate Governance, and Compensation.
• ·Mr. Smith disputed certain statements in the 8-K regarding the dismissal of independent counsel to the Audit Committee (Exhibit 17.5).
• ·Company common stock (par value $0.001) trades on NYSE American, Toronto Stock Exchange, and London Stock Exchange.

17-03-2026

Bitcoin Depot Inc. announced that Elizabeth Simer resigned as Chief Operating Officer on March 11, 2026, with the 8-K filed on March 17, 2026 under Items 5.02 and 9.01. No reasons for the departure or information on a successor were disclosed. The filing includes details on the company's Class A Common Stock (BTM) and Warrants (BTMWW) traded on Nasdaq.

• ·Company headquartered at 8601 Dunwoody Place, Sandy Springs, GA 30350
• ·Registrant is an emerging growth company

17-03-2026

On March 17, 2026, Gentherm Incorporated's Compensation and Talent Committee approved new forms of equity award agreements under the 2023 Equity Incentive Plan, featuring revisions for accelerated vesting upon death, disability, involuntary termination without cause, and qualifying retirement, to be used for future grants to non-employee directors and employees. The filing also discloses details on the proposed transaction involving Gentherm's acquisition of Modine's Performance Technologies business (SpinCo) via spin-off and merger, including planned SEC filings like Form S-4 and Form 10, and urges investors to review them. No financial impacts or performance metrics are provided.

• ·Exhibits include forms effective for 2026 grants filed as 10.1, 10.2, and 10.3.
• ·Gentherm common stock trades as THRM on Nasdaq Global Market.
• ·Related prior filings: Gentherm proxy March 27, 2025; Modine 10-K May 21, 2025, proxy July 9, 2025.

17-03-2026

Neuronetics reported strong Q4 2025 revenue of $41.8 million, up 86% YoY from $22.5 million, and full-year 2025 revenue of $149.2 million, up 99% YoY from $74.9 million, driven primarily by Greenbrook clinic revenue of $23.5 million in Q4 (up 428% YoY) and $87.0 million for the year (up 1,857% YoY). However, core U.S. NeuroStar Advanced Therapy System revenue declined 7% YoY to $14.3 million for the full year with 161 systems shipped, treatment session revenue fell 15% YoY to $43.3 million (down 4% in Q4), gross margins compressed to 48.5% from 72.3%, and the company posted a full-year net loss of $39.1 million despite improvement from $43.7 million prior year. Dan Reuvers was appointed President and CEO effective March 23, 2026, replacing Keith Sullivan, with FY2026 revenue guidance of $160-166 million.

• ·Q4 2025 operating cash flow: $0.9 million (positive)
• ·FY2026 guidance: Q1 revenue $33-35M; gross margin 47-49%; op ex $100-105M; op cash flow $(13)-(17)M
• ·Greenbrook acquisition completed December 2024
• ·Net loss Q4 2025: $(7.2)M or $(0.10)/share vs $(12.7)M or $(0.34)/share prior year
• ·International revenue Q4 up 31% to $1.1M; FY up 29% to $3.1M

17-03-2026

AptarGroup, Inc. announced the retirement of President and CEO Stephan Tanda effective September 1, 2026, with Gael Touya, current President of the Aptar Pharma segment, appointed as his successor in the same role on the Effective Date; Tanda will serve as strategic advisor and Board member through December 31, 2026. The company entered into a new employment agreement with Touya providing an initial base salary of $1.06M, target incentives up to 500% of base via LTI, and a vested €2.51M contribution for forfeited French DB plans, alongside a letter agreement for Tanda maintaining his 2025 compensation levels with 130% STI and 605% LTI targets for 2026. Retention equity awards valued at $1.3M each were granted to CFO Vanessa Kanu (3-year cliff vest) and Aptar Closures President Hedi Tlili (2-year cliff vest).

• ·Touya Employment Agreement initial term: September 1, 2026 to December 31, 2028, auto-extending annually until no later than December 31, 2034.
• ·Touya severance without cause: 1.5x base salary + greater of target or 2-year average bonus, paid over 18 months; post-change in control: 3x salary + 3-year average bonus in lump sum.
• ·Touya noncompetition/nonsolicitation: 18-24 months post-termination depending on reason.
• ·Tanda eligible for COBRA for 18 months post-December 31, 2026, then continued medical access at own expense (FMV + taxes) subject to terminating events.

17-03-2026

Galectin Therapeutics Inc. (NASDAQ:GALT) appointed Henry Brem, M.D., an internationally recognized neurosurgeon-scientist and Henry Brem Professor of Neurosurgery at Johns Hopkins University, as an independent director to its Board of Directors on March 17, 2026. Chairman Richard E. Uihlein highlighted Dr. Brem's expertise in clinical development and regulatory approval as invaluable for advancing belapectin in MASH cirrhosis and portal hypertension. The appointment aims to strengthen the board's scientific and clinical capabilities amid upcoming milestones.

• ·Dr. Brem previously served as Director of the Department of Neurosurgery and Neurosurgeon-in-Chief at The Johns Hopkins Medical Institutions.
• ·Dr. Brem has been continuously funded by the NIH for over four decades and holds multiple patents.
• ·Dr. Brem is a member of the National Academy of Medicine.
• ·Belapectin has Fast Track designation by the U.S. FDA.
• ·Reference to Annual Report on Form 10-K for year ended December 31, 2024.

17-03-2026

Circle Internet Group, Inc. (NYSE: CRCL) announced the appointment of Kirk Koenigsbauer to its Board of Directors effective March 17, 2026, with service on the Compensation and Risk Committees. Mr. Koenigsbauer, currently President & Chief Operating Officer of Microsoft’s Experiences and Devices Group, brings over 30 years of experience in scaling enterprise software, cloud platforms, and security businesses, including leading the launch of Office 365 and Microsoft 365. The appointment aims to bolster Circle’s risk management, governance, and global enterprise capabilities amid its role in digital asset infrastructure.

• ·Mr. Koenigsbauer has served on the board of directors of Thomson Reuters since March 2020.

17-03-2026

Cencora, Inc. announced that Executive Vice President and Chief Financial Officer James F. Cleary, 62, will retire effective June 30, 2026, after serving since November 2018; the company has engaged an executive search firm for internal and external successors, with Cleary assisting through year-end 2026 for a smooth transition. Cencora reaffirmed its fiscal 2026 adjusted diluted EPS guidance of $17.45 to $17.75. The announcement highlights Cleary's contributions to growth and shareholder value, with no changes to guidance indicating stability amid the leadership transition.

• ·Cleary joined Cencora in February 2015 following its acquisition of MWI Veterinary Supply, where he was CEO for over a decade.
• ·Cencora ranked #10 on the Fortune 500 and #18 on the Global Fortune 500.
• ·Fiscal year ended September 30, 2025.

17-03-2026

GE HealthCare Technologies Inc. (Nasdaq: GEHC) appointed Kevin A. Lobo, Chair and Chief Executive Officer of Stryker Corporation (NYSE: SYK), to its Board of Directors effective March 13, 2026. Lobo brings over 25 years of medical technology leadership, including roles at Stryker since 2012, Johnson & Johnson, and others, to support GE HealthCare's innovation and growth priorities. The company operates as a $20.6B business with approximately 54,000 employees across Imaging, Advanced Visualization Solutions, Patient Care Solutions, and Pharmaceutical Diagnostics segments.

• ·GE HealthCare has served patients and providers for 130 years.
• ·Kevin Lobo served as Stryker CEO since October 2012 and Chair since July 2014.
• ·GE HealthCare recognized among 2026 Fortune World’s Most Admired Companies™.

17-03-2026

ReposiTrak (NYSE: TRAK) announced that James R. Gillis, CEO of Gillis & Associates, Inc., will rejoin its Board of Directors effective March 13, 2026, bringing over 35 years of experience in retail supply chain management, M&A, and operational efficiency. Previously, Gillis served as CEO of Source Interlink Companies, Inc., growing it to a $2.5B business servicing over 1,000 retail chains and 110,000 locations. Randy Fields, Chairman and CEO, highlighted Gillis' invaluable strategic perspective for the company's growth and innovation.

• ·James Gillis currently serves as Chairman of SPAR Group and on boards of AST/EQ and TPx, and advises Siris Capital Group and Platinum Equity.
• ·Investor Relations contact: John Merrill (Investor-relations@repositrak.com) or Rob Fink (+1 646.809.4048).
• ·Media contact: Ronald Margulis (+1 908.272.3930).

17-03-2026

NWPX Infrastructure, Inc. approved grants of performance share units (PSUs) and restricted stock units (RSUs) to Named Executive Officers on March 12, 2026, with PSUs comprising 75% of each award at target levels (e.g., 17,068 PSUs for CEO Scott Montross) and entered into new employment agreements effective March 30, 2026, setting base salaries from $410,000 to $815,000. Executive Vice President Miles Brittain will retire on April 3, 2026, but continue as a part-time consultant at an annual salary of $175,000 under a three-year agreement. Jesus Tanguis was appointed as a corporate officer on March 12, 2026, and the 2026 Annual Meeting is scheduled for June 10, 2026, with a record date of April 9, 2026.

• ·PSUs vest in three equal installments on March 31, 2027; March 31, 2028; and March 30, 2029, based on EBITDA margin performance.
• ·RSUs vest in three equal installments on January 15, 2027; January 14, 2028; and January 16, 2029.
• ·Miles Brittain's unvested PSUs forfeit upon resignation; unvested RSUs vesting in 2027 and 2028 affirmed.
• ·Employment agreements include termination provisions: 1x base salary + target STI for non-Cause termination outside change in control; pro-rata vesting for retirement.